Medtronic launches MiniMed 780G with Abbott sensor in US for commercial use

Medtronic has officially released its MiniMed 780G system in the United States, now compatible with Abbotts Instinct sensor. The Instinct sensor employs Abbotts continuous glucose monitoring (CGM) technology and can be worn for up to 15 days. When paired with the MiniMed 780G system, it provides real-time glucose readings and allows the system to automatically adjust insulin delivery every five minutes.

The MiniMed 780G is an automated insulin delivery system designed to reduce the incidence of high and low blood sugar events by frequently adjusting insulin based on current glucose levels. Integrating the Instinct sensor expands Medtronics range of sensor options, joining its Simplera Sync and Guardian 4 sensors. These devices are part of Medtronics growing ecosystem aimed at making diabetes management more personalized and straightforward.

Que Dallara, President of Medtronic Diabetes and Executive Vice President, stated: "This launch represents a significant step in bringing the proven benefits of the MiniMed 780G system to more people living with diabetes. We are creating a smart dosing ecosystem with options so everyone can find a solution suited to their lifestyle. Our mission is to make living with diabetes easier and more predictable, giving people greater freedom and better health every day. We want to deliver confidence and peace of mind so that everyone, including their loved ones, can live boldly."

In April 2025, the US Food and Drug Administration (FDA) approved the use of Medtronics disposable Simplera Sync sensor with the MiniMed 780G system. Last month, Medtronic also began a limited release of its Signia Circular Stapler, featuring Tri-Staple technology for surgical procedures involving the digestive tract.

Author: Olivia Parker